Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19
Clinical trial NCT04662671 · COMPLETED
Trial details
- NCT number
- NCT04662671
- Sponsor
- EmitBio Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2020-12-09
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.